These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15788647)

  • 1. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
    Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
    Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
    van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
    Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustering of hypermethylated genes in neuroblastoma.
    van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
    Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease and endocrine tumour susceptibility.
    Woodward ER; Maher ER
    Endocr Relat Cancer; 2006 Jun; 13(2):415-25. PubMed ID: 16728571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
    Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
    Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
    Eng C; Crossey PA; Mulligan LM; Healey CS; Houghton C; Prowse A; Chew SL; Dahia PL; O'Riordan JL; Toledo SP
    J Med Genet; 1995 Dec; 32(12):934-7. PubMed ID: 8825918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
    Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP
    Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes.
    Bar M; Friedman E; Jakobovitz O; Leibowitz G; Lerer I; Abeliovich D; Gross DJ
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):707-12. PubMed ID: 9497878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
    Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of DcR1, DcR2, DR4, DR5 gene promoters and clinical significance in tongue carcinoma.
    Zhou Y; Zheng S; Luo Q; Huang X; Zhou Y; Li Z
    Am J Otolaryngol; 2019; 40(6):102258. PubMed ID: 31399243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations in sporadic basal cell carcinomas.
    Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
    Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.
    Michalowski MB; de Fraipont F; Plantaz D; Michelland S; Combaret V; Favrot MC
    Pediatr Blood Cancer; 2008 Jan; 50(1):29-32. PubMed ID: 17570703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.